Urinary Tract Infections: Etiology and Emerging Therapeutic Approaches
Abstract
Urinary tract infections (UTIs) are considered a significant public health issue due to their high incidence and prevalence, most notably among women. The potential for complications, including recurrent infections and antibiotic resistance, negatively impacts patient quality of life and correspondingly results in elevated healthcare costs. Efficacy of antibiotic pharmacotherapy has been shown to be limited in the treatment of UTIs. The use of antibiotics has been further exacerbated by the unprecedented spread of antimicrobial-resistant organisms. This paper reviews the microbiome specific to UTIs and the formation of biofilms in UTI patients, and presents the current status of novel biological and chemical approaches designed to inhibit and eradicate biofilms in UTI patients.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.